Chemoenzymatic Synthesis of Chiral Alcohols Relevant to Pharmaceutical Industry
- Weitere Titel
-
Chemoenzymatische Synthese Chiraler Alkohole mit Relevanz für die pharmazeutische Industrie
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Anmerkungen
-
Darmstadt, Technische Universität Darmstadt, Dissertation, 2022
- Schlagwort
-
Alcohols
Pharmaceutical industry
Dạra
- Ereignis
-
Veröffentlichung
- (wo)
-
Darmstadt
- (wer)
-
Universitäts- und Landesbibliothek
- (wann)
-
2022
- Urheber
- Beteiligte Personen und Organisationen
- DOI
-
10.26083/tuprints-00020619
- URN
-
urn:nbn:de:tuda-tuprints-206199
- Rechteinformation
-
Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
15.08.2025, 07:33 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Thai, Nguyen Yen Chi
- Fessner, Wolf-Dieter
- Kolmar, Harald
- Universitäts- und Landesbibliothek
Entstanden
- 2022
Ähnliche Objekte (12)
Elucidation of the molecular and cellular mechanisms of FKBP51-selective inhibitors
Hybrid Multimeric Architectures for Enhanced Receptor Targeting and Intracellular Delivery of Bioactive Cargoes
Antibody-mediated inhibition of MHC class I chain-related protein A shedding for tumor therapy
Modulation of autophagy impacts the fate of senescent skin fibroblasts
Ultra-High-Throughput Single-Cell Functional Screening by Combination of Microfluidics and GMD-FACS
Chemical synthesis of membrane-associated peptides: A model study on influenza virus B protein BM2(1-51)
Targeted Combination Therapy: Discovery and Evaluation of Synergistic Anticancer Effects of Anti-HER2-Duocarmycin Antibody-Drug Conjugates Combined with ATR Inhibitors
Multivalent Functionalized Dextran-Antibody Conjugates for Efficient Tumor Cell Killing
Merge Two into One: Multispecific Symmetric Antibodies for Cancer Immunotherapy
Charakterisierung von Zellwandproteinen des Transglutaminase-Produzenten Streptomyces mobaraensis
Flavors of biotin ligases: From research tools towards biopharmaceutical applications
Identification of novel antagonists against skin relevant molecular targets in mediation of itch and inflammation
Elucidation of the molecular and cellular mechanisms of FKBP51-selective inhibitors
Hybrid Multimeric Architectures for Enhanced Receptor Targeting and Intracellular Delivery of Bioactive Cargoes
Antibody-mediated inhibition of MHC class I chain-related protein A shedding for tumor therapy
Modulation of autophagy impacts the fate of senescent skin fibroblasts
Ultra-High-Throughput Single-Cell Functional Screening by Combination of Microfluidics and GMD-FACS
Chemical synthesis of membrane-associated peptides: A model study on influenza virus B protein BM2(1-51)
Targeted Combination Therapy: Discovery and Evaluation of Synergistic Anticancer Effects of Anti-HER2-Duocarmycin Antibody-Drug Conjugates Combined with ATR Inhibitors
Multivalent Functionalized Dextran-Antibody Conjugates for Efficient Tumor Cell Killing
Merge Two into One: Multispecific Symmetric Antibodies for Cancer Immunotherapy
Charakterisierung von Zellwandproteinen des Transglutaminase-Produzenten Streptomyces mobaraensis
Flavors of biotin ligases: From research tools towards biopharmaceutical applications
Identification of novel antagonists against skin relevant molecular targets in mediation of itch and inflammation
Elucidation of the molecular and cellular mechanisms of FKBP51-selective inhibitors
Hybrid Multimeric Architectures for Enhanced Receptor Targeting and Intracellular Delivery of Bioactive Cargoes
Antibody-mediated inhibition of MHC class I chain-related protein A shedding for tumor therapy
Modulation of autophagy impacts the fate of senescent skin fibroblasts
Ultra-High-Throughput Single-Cell Functional Screening by Combination of Microfluidics and GMD-FACS
Chemical synthesis of membrane-associated peptides: A model study on influenza virus B protein BM2(1-51)
Targeted Combination Therapy: Discovery and Evaluation of Synergistic Anticancer Effects of Anti-HER2-Duocarmycin Antibody-Drug Conjugates Combined with ATR Inhibitors
Multivalent Functionalized Dextran-Antibody Conjugates for Efficient Tumor Cell Killing
Merge Two into One: Multispecific Symmetric Antibodies for Cancer Immunotherapy
Charakterisierung von Zellwandproteinen des Transglutaminase-Produzenten Streptomyces mobaraensis
Flavors of biotin ligases: From research tools towards biopharmaceutical applications